Insiders Amgen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
305.8 ^USD	+1.59%		-0.01%	+6.17%

May. 28	US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	RE
May. 28	Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval	DJ

Chimeric Therapeutics Appoints COO; Shares Rise 4%	May. 01	MT
Abivax appoints new head of quality	Feb. 07	CF
Madrigal Pharmaceuticals Names 3 New Executives	Jan. 29	MT
Eaton Taps Olivier Leonetti as Finance Chief	Jan. 17	DJ
Third Harmonic Bio Names Christopher Murphy as Chief Financial, Business Officer	Jan. 04	MT
Amgen Names James Bradner as Chief Scientific Officer	Dec. 14	MT
Amgen Names James Bradner Chief Scientific Officer	Dec. 14	DJ
Amgen Inc. Announces Executive Changes	Dec. 14	CI
Amgen Insider Sold Shares Worth $572,276, According to a Recent SEC Filing	Dec. 05	MT
US government names first 10 drugs for Medicare price negotiation	23-08-29	RE
Insider Sell: Amgen	23-08-14	MT
Amgen Inc. Announces Management Changes	23-08-04	CI
Amgen Fires Back Against FTC's Antitrust Suit	23-05-16	DJ
Sanofi: departure of global head of R&D	23-02-13	CF
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday	23-01-31	MT
Teva hires ex-Novartis executive to succeed CEO Schultz	22-11-21	RE
Insider Sell: Amgen	22-08-22	MT
EFFECTOR Therapeutics Names Douglas Warner Chief Medical Officer	22-08-08	MT
Amgen Appoints Michael V. Drake to its Board of Directors	22-08-03	CI
Avantor Names Jonathan Peacock Chairman	22-05-13	MT

No results for this search